PYONEPHROSIS

PYONEPHROSIS was reported 83 times

PYONEPHROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 alpha-Glucosidase Inhibitor [EPC] 2 0.0004
1 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 5 0.0002
2 Vitamin D2 Analog [EPC] 1 0.0001
3 Protease Inhibitor [EPC] 5 0.0001
4 Quinolone Antimicrobial [EPC] 1 0.0001
5 Cytochrome P450 3A Inhibitor [EPC] 5 0.0001
6 Aldosterone Antagonist [EPC] 11 0.0001
7 Provitamin D2 Compound [EPC] 2 0.0001
8 Anticholinergic [EPC] 1 0.0001
9 Vitamin D Analog [EPC] 1 0.0001
10 Vitamin D3 Analog [EPC] 1 0.0000
11 Antimetabolite Immunosuppressant [EPC] 1 0.0000
12 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 5 0.0000
13 Angiotensin 2 Receptor Blocker [EPC] 11 0.0000
14 Leukotriene Receptor Antagonist [EPC] 1 0.0000
15 Glycopeptide Antibacterial [EPC] 2 0.0000
16 Penem Antibacterial [EPC] 1 0.0000
17 Nucleoside Analog Antiviral [EPC] 2 0.0000
18 Angiotensin Converting Enzyme Inhibitor [EPC] 3 0.0000
19 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
20 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
21 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
22 Purine Antimetabolite [EPC] 2 0.0000
23 Vitamin D [EPC] 6 0.0000
24 Vitamin B12 [EPC] 6 0.0000
25 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
26 Fluoroquinolone Antibacterial [EPC] 2 0.0000
27 Nitroimidazole Antimicrobial [EPC] 1 0.0000
28 Prostacycline Vasodilator [EPC] 2 0.0000
29 Vitamin C [EPC] 6 0.0000
30 Cardiac Glycoside [EPC] 1 0.0000
31 Proton Pump Inhibitor [EPC] 8 0.0000
32 Folate Analog Metabolic Inhibitor [EPC] 6 0.0000
33 Osmotic Laxative [EPC] 4 0.0000
34 HMG-CoA Reductase Inhibitor [EPC] 5 0.0000
35 Calcium [EPC] 2 0.0000
36 Azole Antifungal [EPC] 2 0.0000
37 Arteriolar Vasodilator [EPC] 1 0.0000
38 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
39 Corticosteroid [EPC] 14 0.0000
40 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
41 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
42 Aminosalicylate [EPC] 1 0.0000
43 5-alpha Reductase Inhibitor [EPC] 1 0.0000
44 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
45 Aromatase Inhibitor [EPC] 1 0.0000
46 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
47 Sulfonylurea [EPC] 1 0.0000
48 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
49 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
50 Opioid Agonist [EPC] 2 0.0000
51 Factor Xa Inhibitor [EPC] 2 0.0000
52 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
53 Insulin Analog [EPC] 3 0.0000
54 Loop Diuretic [EPC] 3 0.0000
55 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
56 Expectorant [EPC] 1 0.0000
57 Nonsteroidal Anti-inflammatory Drug [EPC] 6 0.0000
58 Platinum-based Drug [EPC] 1 0.0000
59 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
60 Platelet Aggregation Inhibitor [EPC] 2 0.0000
61 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
62 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
63 GLP-1 Receptor Agonist [EPC] 1 0.0000
64 Kinase Inhibitor [EPC] 1 0.0000
65 Benzodiazepine [EPC] 1 0.0000